Kyowa Hakko Kirin Files Additional Application For Intramuscular Administration Of Leunase
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin announced Oct. 4 it filed an additional application for intramuscular administration of Leunase (L-Asparaginase), a drug used to treat acute leukemia and malignant lymphoma.